Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Investigation|February 23, 2000
Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581M H Tomasson, D W Sternberg, I R Williams, et al.
British Journal of Haematology|October 4, 2005
Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemiaAyalew Tefferi, Shireen Sirhan, Terra L Lasho, et al.
Blood|January 1, 1995
Clonality in juvenile chronic myelogenous leukemiaL Busque, D G Gilliland, J T Prchal, et al.
Blood|August 15, 1995
TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignanciesY Sato, Y Suto, J Pietenpol, et al.
Blood|August 15, 1994
Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host diseaseJ H Antin, H J Weinstein, E C Guinan, et al.
Molecular and Cellular Biology|April 1, 1996
The t(12;21) translocation converts AML-1B from an activator to a repressor of transcriptionS W Hiebert, W Sun, J N Davis, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 1995
Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemiaT R Golub, G F Barker, S K Bohlander, et al.
Leukemia|March 6, 2009
Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlatesA Tefferi, R L Levine, K-H Lim, et al.
Bone Marrow Transplantation|January 7, 1998
Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasiaK K Ballen, D G Gilliland, E C Guinan, et al.
Leukemia|June 2, 2007
TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutationsA Pardanani, J Hood, T Lasho, et al.
Pageof 9